• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Consumer-directed healthcare bandwagon loses steam

Article

Washington, D.C.-Despite earlier promises that consumer-directed healthcare (CDHC) programs would reduce healthcare spending by encouraging more efficient purchase of health services, consumer confusion and higher out-of-pocket costs seem to be slowing enthusiasm for these plans.

WASHINGTON, D.C.-Despite earlier promises that consumer-directed healthcare (CDHC) programs would reduce healthcare spending by encouraging more efficient purchase of health services, consumer confusion and higher out-of-pocket costs seem to be slowing enthusiasm for these plans.

Cost-shifting to consumers is decelerating, commented Morgan Stanley managing director Christine Arnold at a conference last month sponsored by the Center for Studying Health System Change (HSC).

An estimated 8 million individuals are enrolled in CDHC plans that can link a high-deductible insurance policy to some kind of savings account to cover out-of-pocket costs. But this total includes less than 3 million workers; most CDHC enrollment growth involves individuals with few other choices.

ERIC PLATFORM

One proposal for reviving the CDHC model comes from a coalition of more than 100 large employers that has developed a new option for providing individual health and retirement benefits for workers. The program, developed by the ERISA Industry Committee (ERIC), proposes that competing third-party independent benefit administrators provide these benefits to all individuals, instead of each company offering different plans.

This approach would give employees access to a broad range of quality benefits programs that would be portable and available with equal tax treatment to anyone. The plan would require Congressional changes in tax policy, as well as adoption of an individual health insurance mandate.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.